MRK

NYSE · Pharmaceuticals

Merck & Co. Inc.

S&P 500 Dow Jones Mega-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks

$128.63

+0.30 (+0.23%)

As of Aug 6, 9:30 PM ET ·

Analyst Consensus

Buy

Analysts

Very High

Coverage

Buy 25 69%

Hold 11 31%

Sell 0 0%

Price Target

Analyst Price Target +23.8% upside

Low Target $113.44

Average Target $159.27

High Target $183.82

Current Price $128.63

Current
$128.63

Target
$159.27

$113.44 $159.27 avg $183.82

Scenario Analysis

Bear Case

$113.44

-11.8%

Low target

Base Case

$159.27

+23.8%

Avg target

Bull Case

$183.82

+42.9%

High target

Risk/Reward

3.6x

Highly favorable

Price in Context

52-Week High

$135.05

-4.8% from high

52-Week Low

$77.53

+65.9% from low

50-Day SMA

$109.24

+17.7% vs SMA

200-Day SMA

$90.33

+42.4% vs SMA

RSI (14)

79.1

Overbought

Target vs 52W High

$159.27

+17.9% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+11.9%
RDY Dr. Reddy's Laboratories	Sell	44	52%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+16.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.8%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+30.5%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+172.3%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.7%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+173.7%